2024-10-13 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis

**Company Overview:** CVS Health Corp is a healthcare company that operates pharmacy, health insurance, and healthcare services businesses.

**Performance Analysis:**

1. **Performance vs S&P 500:** CVS has underperformed significantly against the S&P 500 (VOO) over the period analyzed, with a cumulative return of -29.13% compared to the S&P 500's 135.82%. This results in a stark difference of -164.95%, placing CVS at the 1.5 percentile of its historical performance relative to the S&P 500. 

2. **Recent Price Action:** The current closing price of CVS is $66.63. Its price is slightly above the 5-day moving average ($66.16) and well above the 20-day ($61.51) and 60-day ($59.29) moving averages, suggesting potential upward momentum in the short term. 

3. **Technical Indicators:**
    - **RSI:** The RSI value of 85.99 indicates the stock is in overbought territory, suggesting a potential correction in the near future.
    - **PPO:** The PPO value of 0.99 points towards strong positive momentum. 
    - **Relative Divergence:** The positive delta of 0.49 in the recent 20-day relative divergence signifies a short-term upward trend. 
    - **Expected Return:** The expected return of 0.0% reflects the lack of significant potential for exceeding the S&P 500's performance in the next five years.

4. **Recent Earnings and Outlook:** CVS's recent earnings have shown mixed results, with the most recent quarter (2024-08-07) exceeding analysts' estimates. 
    - **EPS:** 1.83
    - **Expected EPS:** 1.73

The previous quarters have shown some fluctuations compared to expectations. This mixed performance suggests a somewhat uncertain outlook for future earnings.

5. **News and Recent Issues:**

Recent market outlook for CVS remains cautiously optimistic. Analysts point towards the company's continued focus on growth through pharmacy and healthcare services, potentially contributing to future earnings growth. The stock has experienced some volatility due to macroeconomic factors and competition within the healthcare industry, but analysts remain generally positive about its long-term prospects.

**Overall Analysis:**

CVS is currently trading at a relatively high price with indicators pointing to potential short-term upward momentum, but the stock's historical performance against the S&P 500 is a significant concern. The overbought RSI level and modest expected return raise caution. However, the recent earnings beat and analysts' positive outlook on the long-term prospects of the company suggest a potential for continued growth.

**Recommendations:**

Investors should consider these factors before making any investment decisions. The overbought conditions, significant underperformance against the S&P 500, and the modest expected return suggest that CVS might be a risky investment at the moment. However, the positive news and the analyst opinions indicate that CVS might be a good long-term investment, given its strategic focus on healthcare services and pharmacy, which are expected to grow in the future. 

**Note:** This information is for educational purposes only and should not be considered as investment advice. Always conduct thorough research and consult with a financial advisor before making any investment decisions. 
